Connect Sign In
3001184
Tiagabine Quantitative, Serum/Plasma
TIAGAB SP
Ordering Recommendation
Optimize drug therapy and monitor patient adherence.
New York DOH Approval Status
This test is New York state approved.
Specimen Required
Patient Preparation
Pre-dose (trough) draw.
Collect
Plain red, lavender (EDTA), or pink (K2EDTA).
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP standard transport tube. (Min: 0.4 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Storage/Transport Temperature
Refrigerated. Also acceptable: Room temperature or frozen.
Unacceptable Conditions
Polymer gel separation tube (SST or PST).
Remarks
Stability
Ambient: 1 month; Refrigerated: 1 month; Frozen: 48 months
Methodology
Quantitative High Performance Liquid Chromatography-Tandem Mass Spectrometry
Performed
Varies
Reported
8-11 days
Reference Interval
Refer to report
Interpretive Data
Compliance Category
Performed by non-ARUP Laboratory
Note
Hotline History
N/A
CPT Codes
80199
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3001185 | Tiagabine Quantitative, Serum/Plasma | 21565-7 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- Gabitril
Tiagabine Quantitative, Serum/Plasma
National Medical Services (NMS)
